Conference Coverage (Retrovirus)

"Reason for Hope Amid Hype"

Published in AIDS Weekly, February 24th, 1997

Why look for new anti-HIV drugs when media reports have declared that the advent of triple-drug combinations signals the end of AIDS'

The answer, in a nutshell, is that the complex dosages, toxicities, and drug interactions of these treatments make them hard for patients to take and difficult for doctors to prescribe.

But new drugs under development - and new combinations including existing drugs - hold the promise of improved, individualized treatment strategies.

"There is reason for hope amid the hype," said long-time AIDS clinician Ann Collier of the University of Washington, Seattle.

Collier discussed the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (1997-02-24)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry